We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bioquell | LSE:BQE | London | Ordinary Share | GB0004992003 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 597.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
07/2/2019 10:54 | All done now ... it's a shame that another successful UK company is no more. | bountyhunter | |
24/1/2019 12:59 | Thanks Dab. | bountyhunter | |
24/1/2019 12:53 | Not yet. Interactive Investors indicate January 30th. Hope that is of some help. | dab26 | |
24/1/2019 12:42 | anyone received their cash yet? | bountyhunter | |
16/1/2019 12:24 | Goodebye Bioquell, a great share to have held! Under the terms of the Scheme, the holders of Scheme Shares are entitled to receive 590 pence for each Scheme Share held at the Scheme Record Time, being 6.00 p.m. (London time) on 15 January 2019. The latest date for the dispatch of cheques to Scheme Shareholders and settlement through CREST is as soon as practicable after today's date, and in any event within 14 days of today's date. Dealings in Bioquell Shares were suspended with effect from 6.00 p.m. (London time) on 15 January 2019. SEE HEADER FOR FULL DETAILS | bountyhunter | |
11/1/2019 19:20 | Hi bb, sorry just seen your message(!), I'll take a look. | bountyhunter | |
07/1/2019 09:38 | Good morning bountyhunter. One to look at imv is OMG, which rather like BQE back a while is debt free, just issued a special divi and coming out of a big investment cycle with world leading products. | bbluesky | |
01/1/2019 15:27 | now I just need to work out where to reinvest the proceeds when they arrive whenever that may be! | bountyhunter | |
01/1/2019 15:19 | 🎆🍾 🎆HAPPY NEW YEAR!🎆 🎆🍾 | bountyhunter | |
01/12/2018 08:15 | Apparently Bill Gates owns 12% of Ecolab... | bountyhunter | |
30/11/2018 18:26 | Yes this is a decent price and well done to the BoD! Now I just need to find another cash rich well run takeover prospect. I'll check out BIOM but any other ideas? MTFB with a new antibiotic is interesting but the chart is rubbish! | bountyhunter | |
30/11/2018 18:25 | Yes this is a decent price and well done to the BoD! Now I just need to find another cash rich well run takeover prospect. I'll check out BIOM but any other ideas? MTFB is interesting but the chart is rubbish! | bountyhunter | |
30/11/2018 18:09 | Well this is a fantastic deal for holders. A real win for Chris Mills whose funds hold a big percentage. What brilliant shareholder value creation. I held these much lower, but at least benefit indirectly through North Atlantic and Oryx. | topvest | |
30/11/2018 15:39 | Nice one Ian , Chris did good getting you You now deserve a 25% pay rise | buywell3 | |
30/11/2018 13:16 | Consider BIOM (Biome technologies & bioplastics). Small cap but all good ahead of bioplastics based alternatives to nondegradable plastics. | marmar80 | |
30/11/2018 12:07 | Price is good, but now I need to find another growth company with an undervalued share price. Perhaps ST will help again. | 18bt | |
30/11/2018 09:24 | thanks, now we know why it went up so far and fast previously! (thankfully not higher than todays agreed offer though) | bountyhunter | |
30/11/2018 09:22 | Congratulations. | countless | |
30/11/2018 08:45 | Well done holders!! | funkmasterp12 | |
30/11/2018 07:44 | Yup. Very pleased. Well done management. | wjccghcc | |
30/11/2018 07:34 | Very pleased with the offer in the current market , well done to BQE management | modform | |
30/11/2018 07:17 | Well done. BQE holders have their Friday feeling | mirabeau | |
30/11/2018 07:08 | Offer at 590p (40% premium) - fantastic news!!! 😁😁 | bountyhunter |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions